[{"address1": "700 Quince Orchard Road", "city": "Gaithersburg", "state": "MD", "zip": "20878", "country": "United States", "phone": "240 268 2000", "website": "https://www.novavax.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.", "fullTimeEmployees": 952, "companyOfficers": [{"maxAge": 1, "name": "Mr. John Charles Jacobs M.B.A.", "age": 57, "title": "President, CEO & Director", "yearBorn": 1967, "fiscalYear": 2023, "totalPay": 1329651, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John Joseph Trizzino B.S., M.B.A.", "age": 64, "title": "President & COO", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 670550, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James Patrick Kelly C.F.A.", "age": 58, "title": "Executive VP, CFO & Treasurer", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 716175, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark  Casey", "age": 61, "title": "Executive VP, Chief Legal Officer & Corporate Secretary", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 137357, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Richard P. Crowley", "age": 67, "title": "Executive VP & COO", "yearBorn": 1957, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Troy  Morgan Esq., J.D.", "age": 53, "title": "Senior VP, Deputy General Counsel & Chief Compliance Officer", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Erika S. Trahan", "title": "Associate Director of Investor & Public Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ian J. Watkins", "age": 61, "title": "Executive VP & Chief Human Resources Officer", "yearBorn": 1963, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Silvia  Taylor M.B.A.", "title": "Executive VP and Chief Corporate Affairs & Advocacy Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Henrietta  Ukwu FACP FRAPS, M.D.", "age": 56, "title": "Executive VP & Chief Regulatory Officer", "yearBorn": 1968, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 5, "compensationRisk": 7, "shareHolderRightsRisk": 5, "overallRisk": 5, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "irWebsite": "http://www.novavax.com/go.cfm?do=Stock.GetQuote", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 7.07, "open": 7.01, "dayLow": 6.12, "dayHigh": 7.1642, "regularMarketPreviousClose": 7.07, "regularMarketOpen": 7.01, "regularMarketDayLow": 6.12, "regularMarketDayHigh": 7.1642, "payoutRatio": 0.0, "beta": 3.144, "forwardPE": -41.6875, "volume": 13128530, "regularMarketVolume": 13128530, "averageVolume": 5098061, "averageVolume10days": 6816790, "averageDailyVolume10Day": 6816790, "bid": 6.41, "ask": 6.82, "bidSize": 56, "askSize": 56, "marketCap": 1137168256, "fiftyTwoWeekLow": 4.1, "fiftyTwoWeekHigh": 23.86, "priceToSalesTrailing12Months": 1.6670063, "fiftyDayAverage": 7.238, "twoHundredDayAverage": 9.8924, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 413183808, "profitMargins": -0.27486, "floatShares": 135577182, "sharesOutstanding": 160844000, "sharesShort": 41028051, "sharesShortPriorMonth": 37551429, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.2551, "heldPercentInsiders": 0.08766, "heldPercentInstitutions": 0.6005, "shortRatio": 7.18, "shortPercentOfFloat": 0.31780002, "impliedSharesOutstanding": 170490000, "bookValue": -3.889, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -187499008, "trailingEps": -1.23, "forwardEps": -0.16, "lastSplitFactor": "1:20", "lastSplitDate": 1557446400, "enterpriseToRevenue": 0.606, "enterpriseToEbitda": -2.252, "52WeekChange": 0.5547786, "SandP52WeekChange": 0.07995045, "quoteType": "EQUITY", "currentPrice": 6.67, "targetHighPrice": 25.0, "targetLowPrice": 9.0, "targetMeanPrice": 15.16667, "targetMedianPrice": 14.5, "recommendationMean": 2.14286, "recommendationKey": "buy", "numberOfAnalystOpinions": 6, "totalCash": 923118016, "totalCashPerShare": 5.739, "ebitda": -183435008, "totalDebt": 263471008, "quickRatio": 0.893, "currentRatio": 0.978, "totalRevenue": 682161984, "revenuePerShare": 4.482, "returnOnAssets": -0.086339995, "grossProfits": 112522000, "freeCashflow": -175641744, "operatingCashflow": -87263000, "revenueGrowth": -0.697, "grossMargins": 0.16495001, "ebitdaMargins": -0.2689, "operatingMargins": -1.4208901, "financialCurrency": "USD", "symbol": "NVAX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Novavax, Inc.", "longName": "Novavax, Inc.", "marketState": "CLOSED", "regularMarketChangePercent": -5.6577096, "regularMarketPrice": 6.67, "priceEpsCurrentYear": 16.11111, "fiftyDayAverageChange": -0.56799984, "fiftyDayAverageChangePercent": -0.07847469, "twoHundredDayAverageChange": -3.2223997, "twoHundredDayAverageChangePercent": -0.325745, "priceToBook": -1.7150939, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.1 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 818173800000, "postMarketChangePercent": -0.899549, "postMarketPrice": 6.61, "postMarketChange": -0.0599999, "regularMarketChange": -0.4000001, "regularMarketDayRange": "6.12 - 7.1642", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 5098061, "fiftyTwoWeekLowChange": 2.5700002, "fiftyTwoWeekLowChangePercent": 0.6268293, "fiftyTwoWeekRange": "4.1 - 23.86", "fiftyTwoWeekHighChange": -17.19, "fiftyTwoWeekHighChangePercent": -0.72045267, "fiftyTwoWeekChangePercent": 55.47786, "dividendDate": 1557446400, "earningsTimestamp": 1740663000, "earningsTimestampStart": 1746707400, "earningsTimestampEnd": 1747053000, "earningsCallTimestampStart": 1740663000, "earningsCallTimestampEnd": 1740663000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.23, "epsForward": -0.16, "epsCurrentYear": 0.414, "corporateActions": [], "postMarketTime": 1745625589, "regularMarketTime": 1745611201, "exchange": "NMS", "messageBoardId": "finmb_350381", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "Novavax", "trailingPegRatio": null, "__fetch_time": "2025-04-26"}]